Champalimaud Research Symposium 2018
to Behaviour & Neural Systems
The 2018 Champalimaud Research Symposium, Quantitative approaches to Behaviour and Neural Systems, will be held in Lisbon, Portugal, from the 23rd to the 26th of October 2018. The goal of the Symposium is to define and address the challenges present in developing theory-oriented quantitative approaches to understanding the behaviour of organisms, the function and structure of their nervous systems, and the emergence of organization in complex adaptive systems. Seminars will span a range of levels from pure theory to data analysis and experimental work. As well as highlighting detailed investigations of specific problems, talks will emphasize the identification of general principles and key theoretical frameworks that should lay the foundation of the neuroscience and biology of the future. The Symposium will be structured as a single-track programme in which talks by invited speakers, as well as speakers selected from submitted abstracts, are interleaved with poster sessions where symposia participants present their research. Discussion sessions with panels composed by invited speakers will also be part of the programme. The event will be held at our Centre, in a stunning setting on the waterfront in Lisbon, and will also feature a social programme which will give participants the chance to explore this beautiful and historic city.
Maria Neimark Geffen
Michael Orger and Alfonso Renart
ORGANISERS AND TECHNICAL SUPPORT
Patrícia Correia, Pedro Alves, Ana Casaca, Anna Hobbiss, Gil Costa, Marta Correia, Catarina Ramos
Meet our SpeakersThey are focused in developing theory-oriented quantitative approaches to understanding the behaviour of organisms, the function and structure of their nervous systems, and the emergence of organization in complex adaptive systems.
Inaugurated on October 5th 2010, the Champalimaud Centre for the Unknown is now a part of the important riverside area of Belém, near the magnificent Tower of Belém. This area, where the river Tejo meets the Atlantic Ocean, is of great historical significance as the great Portuguese pioneers sailed from this location to discover the “unknown” in the XV and XVI centuries.
The presence of the Champalimaud Centre for the Unknown leverages this historical heritage by creating an inspirational link between the discoveries of yesteryear and the epic adventure of scientific research. Here, everything converges in the creation of a unique atmosphere for the development of the most advanced multidisciplinary and translational research in the field of biomedicine. The building’s contemporary architecture, along with its functionality, offers outstanding conditions to investigators, academics and health professionals, from Portugal and beyond, to carry out work oriented towards excellence and practical results.
The Champalimaud Centre for the Unknown covers an area of 60,000m2 facing the river Tejo and comprises three large areas. The main building houses the Champalimaud Clinical Centre’s diagnostic and treatment facilities, an indoor garden, research laboratories and administrative services, all interlinked to promote discussion and collaboration between scientists, clinicians and other professionals. A tropical pergola-covered garden is at the heart of this structure.
The Champalimaud Centre for the Unknown is a state-of-the-art facility for science, medicine, technology and public use.
Champalimaud Centre for the Unknown
Media and Publishing partner
Cells (ISSN 2073-4409) is an international open access journal of cell biology, molecular biology, and biophysics, which is published monthly by MDPI AG, Basel, Switzerland. Manuscripts regarding original research and ideas will be particularly welcomed. We also accept reviews, conference papers, communications, short notes and case reports. Cells maintains rigorous peer-review and a rapid publication process. Research articles, reviews, and other contents are released on the Internet immediately after acceptance. It is indexed in *SCIE* and PubMed. It is eligible for inclusion in the Journal Citation Reports (JCR) and the Impact Factor (2017) is 4.829. Cells has entered the ranking in the category ‘Cell Biology’ (SCIE) at 55 of 190 (Q2). To submit to Cells click here
Good health makes life better. Wellcome Trust wants to improve health for everyone by helping great ideas to thrive. That’s why we support thousands of curious, passionate people all over the world to explore great ideas, at every step of the way from discovery to impact. We also identify priority areas where we can give focused, intensive support when there are real opportunities to transform lives, or we can drive reform to ensure that ideas reach their full potential For more information visit: https://wellcome.ac.uk/
Linde Healthcare iis a global business unit of The Linde Group. It is present in over 50 countries, and has been extensively involved in the development of therapies and diagnostic procedures, where gases, gas technology or gas competence is needed. In surgeries, emergency services, intensive care, clinics and Investigation Centres, the company offers a broad spectrum of products and services to effectively support medical practitioners and their patients. Linde Healthcare co-operates with researchers in hospitals and universities as well as a global network of physicians, clinicians and technicians working on the frontlines
Multi Channel Systems focuses on the development of precision scientific measuring instrumentation and equipment in the field of electrophysiology for research groups at universities and for the pharmaceutical industry. We provide solutions for extra-cellular recordings with microelectrode arrays in vitro and in vivo as well as for electrical stimulation. Moreover, we offer devices for automated RNA injection and for automated two-electrode voltage-clamp recording of Xenopus oocytes. Because of their modular principle, our products can be extended and adjusted to your specific experimental needs. Apart from their flexibility, our products fit into your laboratories because of their size.
Together with our Smart Ephys partner brands HEKA Elektronik Dr. Schulze GmbH, Triangle BioSystems International and Warner Instruments as well as our well-established distribution partners, we serve laboratories, research institutes and the pharmaceutical industry all over the world. Over 20 years of experience and our international distribution network make us the global market leader in the field of non-clinical electrophysiology with microelectrode arrays.
Sutter Instrument sets the highest standards for performance and innovation. New products include the Lambda 421 Optical Beam Combiner, TRIO 3-axis micromanipulator, BOB, an open-design upright microscope, and dPatch (Digital Patch Clamp Amplifier), an all-in-one low-noise single or dual patch clamp amplifier, onboard D/A conversion, data acquisition system, and powerful SutterPatch software.”
By partnering with the 2018 Champalimaud Research Symposium, your organisation will be associated with one of the key scientific international events held in Portugal and engage with the national and international scientific community dedicated to disease oriented research, with a special focus on modern physiology in development, ageing, immunity and cancer.